Latest Insights

Blossom publishes several articles per week that provide commentary on the developing field of psychedelics as medicine. Here we analyse the latest research, provide overviews of research areas, and conduct interviews with leading psychedelic figures.

Integration of psychedelic experiences can be key | How the integration after psychedelics can be vital for positive therapeutic outcomes
Category: Top Papers
Published: 2022-01-11
From drug policy reform to virtual reality, psychedelics are entering the 21st century | Guest post for Drugs&Me
Category: Business
Published: 2022-01-10
In the Research Briefing of January 10th: 1) Psilocybin can be administered safely for up to six people simultaneously 2) An Open Science approach toward MDMA synthesis 3) Nitrous Oxide could be the next antidepressant
Category: Briefings
Published: 2022-01-10
This is all the other psychedelic research that came out in January 2022.
Category: Links
Published: 2022-01-05
December was another busy month in the world of psychedelic research as 2021 came to a close. The benefits of microdosing remain in dispute, the use of virtuality reality in tandem with psychedelics is further discussed, while we simultaneously gained further insight as to how different psychedelics work in the brain for different disorders, through both experiments and reviews.
Category: Overviews
Published: 2022-01-04
In the Research Briefing of December 20th: 1) New double-blind study doesn't find benefits of microdosing 2) The negative post-acute effects of MDMA appear to be absent in the clinical setting
Category: Briefings
Published: 2021-12-17
To better understand the science of psychedelics, and how we can make the bridge to implementing them in practice, Blossom is conducting a series of interviews with psychedelic scientists. Our editor-at-large, George Fejer, speaks to David Glowacki, one of the world's leaders in the use of virtual reality applied to scientific simulation and visualization.
Category: Research
Published: 2021-12-13
Microdosing is becoming more popular every day. From Hollywood to small towns all across the word. Is there scientific merit to it, or all placebo? And does a new paper prove the benefits of microdosing?
Category: Column
Published: 2021-12-10
How can we marry psychedelic capitalism & reciprocity? | Blossom speaks to Woven Science on their approach to indigenous communities, how they can give back, and provide a template for others to do so.
Category: Business
Published: 2021-12-10
November proved to be another productive month for psychedelic research. A variety of surveys looked at how psychedelics alter beliefs, reduce opioid use, and the effects of microdosing. A finished Phase I trial clear 5-MeO-DMT for the next step, cannabis intensifies a psychedelic experience, and psychedelics may help with Alzheimer's.
Category: Overviews
Published: 2021-12-08

Psychedelic Insights

Blossom provides timely and timeless information on psychedelics as medicine. Our blogs, articles, and interviews help contextualize this quickly developing field of psychedelic research and how this will be implemented.

Become a psychedelic insider!

With a free Blossom membership you will always be in the know.

📰 Weekly newsletter about the psychedelic research

✔️ Unlimited access to our database and original articles

🖊️ Add (private) notes and comments to each page

Make an account